Assessment of mitochondrial membrane potential in situ using single potentiometric dyes and a novel fluorescence resonance energy transfer technique

Methods in Cell Biology

Volumn 65, Issue 65, 2001, Pages 285-309

  Dykens, James A ^a   Stout, Amy K ^a  

^a Migenix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BONGKREKIC ACID; CALCIUM; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; COLORING AGENT; CYCLOSPORIN; ENZYME INHIBITOR; IONOMYCIN; IONOPHORE; RHODAMINE; RUTHENIUM RED; TETRAMETHYLRHODAMINE;

ARTICLE; CELL LINE; CELL MEMBRANE POTENTIAL; CHEMISTRY; DRUG EFFECT; ENERGY TRANSFER; HUMAN; INTRACELLULAR MEMBRANE; METABOLISM; METHODOLOGY; MITOCHONDRION; PERMEABILITY; PHYSIOLOGY; SPECTROFLUOROMETRY;

ANTI-BACTERIAL AGENTS; BONGKREKIC ACID; CALCIUM; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL LINE; COLORING AGENTS; CYCLOSPORINE; ENERGY TRANSFER; ENZYME INHIBITORS; HUMANS; INTRACELLULAR MEMBRANES; IONOMYCIN; IONOPHORES; MEMBRANE POTENTIALS; MITOCHONDRIA; PERMEABILITY; RHODAMINES; RUTHENIUM RED; SPECTROMETRY, FLUORESCENCE;

EID: 0035229641     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(01)65018-0     Document Type: Article

References (74)

1. Anderson, W. M., Wood, J. M., and Anderson, A. C. (1993). Inhibition of mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase by oxacarbocyanine dyes: A structure-activity study. Biochem. Pharmacol. 45, 2115-2122.
2. Andreyev, A., and Fiskum, G. (1999). Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death Differ. 6, 825-832.
3. Andreyev, A. Y., Fahy, B., and Fiskum, G. (1998). Cytochrome c release from brain mitochondria is independent of the mitochondrial permeability transition. FEBS Lett. 439, 373-376.
4. Antunes, F., Salvador, A., Marinho, H. S., Alves, R., and Pinto, R. E. (1996). Lipid peroxidation in mitochondrial inner membranes. I. An integrative kinetic model. Free Radic. Biol. Med. 21, 917-943.
5. Beal, M. F., Bodis-Wollner, I., and Howell, N. (1997). "Neurodegenerative Diseases: Mitochondria and Free Radicals in Pathogenesis." Wiley, New York.
6. Bernardi, P. (1999). Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol. Rev. 79, 1127-1255.
7. Bernardi, P., Colonna, R., Costantini, P., Eriksson, O., Fontaine, E., Ichas, F., Massari, S., Nicolli, A., Petronilli, V., and Scorrano, L. (1998). The mitochondrial permeability transition. Biofactors 8, 273-281.
8. Bunting, J. R. (1992a). A test of the singlet oxygen mechanism of cationic dye photosensitization of mitochondrial damage. Photochem. Photobiol. 55, 81-87.
9. Bunting, J. R. (1992b). Influx and efflux kinetics of cationic dye binding to respiring mitochondria. Biophys. Chem. 42, 163-175.
10. Bunting, J. R., Phan, T. V., Kamali, E., and Dowben, R. M. (1989). Fluorescent cationic probes of mitochondria: Metrics and mechanism of interaction. Biophys. J. 56, 979-993.
11. Cassarino, D. S., and Bennett, J. P., Jr. (1999). An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneratton. Brain Res. Brain Res. Rev. 29, 1-25.
12. Di Lisa, F., Blank, P. S., Colonna, R., Gambassi, G., Silverman, H. S., Stern, M. D., and Hansford, R. G. (1995). Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J. Physiol. (Lond) 486, 1-13.
13. +: Implications for neurodegeneration. J. Neurochem. 63, 584-591.
14. Dykens, I. A. (1995). Mitochondrial radical production and mechanisms of oxidative excitotoxicity. In "The Oxygen Paradox" (K. J. A. Davies and F. Ursini, eds.), pp. 453-467. Cleup Press.
15. Dykens, J. A. (1997). Mitochondrial free radical production and the etiology of neurodegenerative disease. In "Neurodegenerative Diseases: Mitochondria and Free Radicals in Pathogenesis" (M. F. Beal, I. Bodis-Wollner, and N. Howell, eds.), pp. 29-55. Wiley, New York.
16. Dykens, J. A. (1999). Free radicals and mitochondrial dysfunction in excitotoxicity and neurodegenerative diseases. In "Cell Death and Diseases of the Nervous System" (V. E. Koliatos and R. R. Ratan, eds.), pp. 45-68. Humana Press, New Jersey.
17. Dykens, J. A., Moos, W. H., and Davis, R. E. (1999). An introduction to mitochondrial genetics and physiology. Drug Dev. Res. 46, 2-13.
18. Efferth, T., Lohrke, H., and Volm, M. (1989). Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res. 9, 1633-1637.
19. Ehrenberg, B., Montana, V., Wei, M.-D., Wuskell, J. P., and Loew, L. M. (1988). Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys. J. 53, 785-794.
20. Emaus, R. K., Grunwald, R., and Lemasters, J. J. (1986). Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: Spectral and metabolic properties. Biochim. Biophys. Acta 850, 436-448.
21. Farkas, D. L., Wei, M. D., Febbroriello, P., Carson, J. H., and Loew, L. M. (1989). Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys. J. 56, 1053-1069.
22. Fiskum, G., Murphy, A. N., and Beal, M. F. (1999). Mitochondria in neurogeneration: Acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab. 19, 351-369.
23. Floryk, D., and Houstek, J. (1999). Tetramethyl rhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin. Biosci. Rep. 19, 27-34.
24. Fontaine, E., and Bernardi, P. (1999). Progress on the mitochondrial permeability transition pore: Regulation by complex I and ubiquinone analogs. J. Bioenerg. Biomembr. 31, 335-345.
25. Garner, D. L., Thomas, C. A., Joerg, H. W., DeJarnette, J. M., and Marshall, C. E. (1997). Fluorometric assessments of mitochondrial function and viability in cryopreserved bovine spermatozoa. Biol. Reprod. 57, 1401-1406.
26. Gottesman, M. M., and Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
27. Hall, J. G., Cory, A. H., and Cory, J. G. (1999). Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1. Adv. Enzyme Regul. 39, 113-128.
28. Huser, J., Rechenmacher, C. E., and Blatter, L. A. (1998). Imaging the permeability pore transition in single mitochondria. Biophys. J. 74, 2129-2137.
29. Iwase, H., Takatori, T., Nagao, M., Iwadate, K., and Nakajima, M. (1996). Monoepoxide production from linoleic acid by cytochrome c in the presence of cardiolipin. Biochem Biophys. Res. Commun. 222, 83-89.
30. Jachez, B., Boesch, D., Grassberger, M. A., and Loor, F. (1993). Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. Anticancer Drugs 4, 223-229.
31. Jackson, J. B., and Nicholls, D. G. (1986). Methods for the determination of membrane potential in bioenergetic systems. Methods Enzymol. 127, 557-577.
32. Johnson, I. (1998). Fluorescent probes for living cells. Histochem. J. 30, 123-140.
33. Johnson, L. V., Walsh, M. L., Bockus, B. J., and Chen, L. B. (1981). Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88, 526-535.
34. Juan, G., Cavazzoni, M., Saez, G. T., and O'Connor, J. E. (1994). A fast kinetic method for assessing mitochondrial membrane potential in isolated hepatocytes with rhodamine 123 and flow cytometry. Cytometry 15, 335-342.
35. Kamo, N., Muratsugu, M., Hongoh, R., and Kobatake, Y. (1979). Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 49, 105-121.
36. Keij, J. F., Bell-Prince, C., and Steinkamp, J. A. (2000). Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and MitoTracker Green is affected by mitochondrial membrane potential altering drugs. Cytometry 39, 203-210.
37. Kessel, D., Beck, W. T., Kukuruga, D., and Schulz, V. (1991). Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51, 4665-4670.
38. Kuhnel, J. M., Perrot, J. Y, Faussat, A. M., Marie, J. P., and Schwaller, M. A. (1997). Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia 11, 1147-1155.
39. Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., and Herman, B. (1998). The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196.
40. Lemasters, J. J., Qian, T., Bradham, C. A., Brenner, D. A., Cascio, W. E., Trost, L. C., Nishimura, Y., Nieminen, A. L., and Herman, B. (1999). Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr. 31, 305-319.
41. Loew, L. M., Tuft, R. A., Carrington, W., and Fay, F. S. (1993). Imaging in five dimensions: Time-dependent membrane potentials in individual mitochondria. Biophys. J. 65, 2396-2407.
42. Maftah, A., Petit, J. M., Ratinaud, M. H., and Julien, R. (1989). 10-N nonyl-acridine orange: A fluorescent probe which stains mitochondria independently of their energetic state. Biochem. Biophys. Res. Commun. 164, 185-190.
43. Mason, W. T. (1993). "Fluorescent and Luminescent Probes for Biological Activity." Academic Press, San Diego.
44. Moos, W. H., Dykens, J. A., and Davis, R. E. (1999). Mitochondrial biology and neurodegenerative diseases. Pharm. News 6, 15-29.
45. Mathur, A., Hong, Y., Kemp, B. K., Barrientos, A. A., and Erusalimsky, J. D. (2000). Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc. Res. 46, 126-138.
46. Matsumoto, B. (1992). Cell biological applications of confocal microscopy. In "Methods in Cell Biology," Vol. 38, Academic Press, San Diego.
47. Mitchell, P., and Moyle, J. (1969). Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur. J. Biochem. 7, 471-184.
48. Murphy, A. N., Fiskum, G., and Beal, M. F. (1999). Mitochondrial ion neurodegeneration: Bioenergetic function in cell life and death. J. Cereb. Blood Flow Metab. 19, 231-245.
49. Nelson, E. J., Zinkin, N. T., and Hinkle, P. M. (1998). Fluorescence methods to assess multidrug resistance in individual cells. Cancer Chemother Pharmacol. 42, 292-299.
50. Nicholls, D. G. (1974). The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. Eur. J. Biochem. 50, 305-315.
51. Nicholls, D. G., and Ward, M. W. (2000). Mitochondrial membrane potential and neuronal glutamate excitotoxicity:mortality and millivolts. Trends Neurosci. 23, 166-174.
52. Nicholls, D. G., and Budd, S. L. (1998). Neuronal excitotoxicity: The role of mitochondria. Biofactors 8, 287-299.
53. Nicholls, D. G., and Ferguson, S. J. (1992). "Bioenergetics 2," Academic Press, London.
54. Nuydens, R., Novalbos, J., Dispersyn, G., Weber, C., Borgers, M., and Geerts, H. (1999). A rapid method for the evaluation of compounds with mitochondria-protective properties. J. Neurosci. Methods 15, 153-159.
55. Padan, E., and Rottenberg, H. (1973). Respiratory control and the proton electrochemical gradient in mitochondria. Eur. J. Biochem. 40, 431-437.
56. Petronilli, V., Miotto, G., Canton, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1998). Imaging the mitochondrial permeability transition pore in intact cells. Biofactors 8, 263-272.
57. Reers, M., Smiley, S. T., Mottola-Hartshorn, C., Chen, A., Lin, M., and Chen, L. B. (1995). Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 260, 406-417.
58. Reynolds, I. J. (1999). Mitochondrial membrane potential and the permeability transition in excitotoxicity. Ann. N.Y. Acad. Sci. 893, 33-41.
59. Rottenberg, H. (1979). The measurement of membrane potential and delta pH in cells, organelles, and vesicles. Methods Enzymol. 55, 547-569.
60. Rottenberg, H. (1984). Membrane potential and surface potential in mitochondria: Uptake and binding of lipophilic cations. J. Membr. Biol. 81, 127-138.
61. Rottenberg, H., and Wu, S. (1998). Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim. Biophys. Acta 1404, 393-404.
62. 6(3): A useful dye for staining the endoplasmic reticulum. Biotech. Histochem. 72, 253-258.
63. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 411, 77-82.
64. Scaduto, R. C., Jr., and Grotyohann, L. W. (1999). Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 76, 469-477.
65. Scanlon, J. M., and Reynolds, I. J. (1998). Effects of oxidants and glutamate receptor activation on mitochondrial membrane potential in rat forebrain neurons. J. Neurochem. 71, 2392-2400.
66. Scorrano, L., Petronilli, V., Colonna, R., Di Lisa, F., and Bernardi, P. (1999). Chloromethyltetramethylrosamine (Mitotracker Orange) induces the mitochondrial permeability transition and inhibits respiratory complex I: Implications for the mechanism of cytochrome c release. J. Biol. Chem. 274, 24657-24663.
67. Scott, I. D., and Nicholls, D. G. (1980). Energy transduction in intact synaptosomes: Influence of plasma-membrane depolarization on the respiration and membrane potential of internal mitochondria determined in situ. Biochem. J. 186, 21-33.
68. Skulachev, V. P. (1999). Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol. Aspects Med. 20, 139-184.
69. Siesjo, B. K., Elmer, E., Janelidze, S., Keep, M., Kristian, T., Ouyang, Y. B., and Uchino, H. (1999). Role and mechanisms of secondary mitochondrial failure. Acta Neurochir. Suppl. (Wien) 73, 7-13.
70. Shults, C. W., Haas, R. H., and Beal, M. F. (1999). A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease. Biofactors 9, 267-272.
71. Sureda, F. X., Gabriel, C., Comas, J., Pallas, M., Escubedo, E., Camarasa, J., and Camins, A.(1999). Evaluation of free radical production, mitochondrial membrane potential and cytoplasmic calcium in mammalian neurons by flow cytometry. Brain Res. Brain Res. Protoc. 4, 280-287.
72. Terasaki, M., and Reese, T. S. (1992). Characterization of endoplasmic reticulum by colocalization of BiP and dicarbocyanine dyes. J. Cell Sci. 101, 315-322.
73. Webb, M., Raphael, C. L., Asbahr, H., Erber, W. N., and Meyer, B. F. (1996). The detection of rhodamine 123 efflux at low levels of drug resistance. Br. J. Haematol. 93, 650-655.
74. Wilson, H. A., Seligmann, B. E., and Chused, T. M. (1985). Voltage-sensitive cyanine dye fluorescence signals in lymphocytes: plasma membrane and mitochondrial components. J. Cell. Physiol. 125, 61-71.